Advertisement
UK markets close in 16 minutes
  • FTSE 100

    8,065.65
    +25.27 (+0.31%)
     
  • FTSE 250

    19,588.49
    -130.88 (-0.66%)
     
  • AIM

    752.84
    -1.85 (-0.25%)
     
  • GBP/EUR

    1.1654
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2489
    +0.0026 (+0.21%)
     
  • Bitcoin GBP

    50,839.94
    -1,284.44 (-2.46%)
     
  • CMC Crypto 200

    1,368.92
    -13.66 (-0.99%)
     
  • S&P 500

    5,006.53
    -65.10 (-1.28%)
     
  • DOW

    37,822.02
    -638.90 (-1.66%)
     
  • CRUDE OIL

    82.33
    -0.48 (-0.58%)
     
  • GOLD FUTURES

    2,344.90
    +6.50 (+0.28%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,893.58
    -195.12 (-1.08%)
     
  • CAC 40

    8,014.01
    -77.85 (-0.96%)
     

Editas Medicine, Inc. (EDIT) Q4 2020 Earnings Call Transcript

Editas Medicine, Inc. (EDIT) Q4 2020 Earnings Call Transcript

As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements, as a result of various important factors, including those discussed in the Risk Factors section of our most recent quarterly report on Form 10-Q, which is on file with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date.